Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery - an autoradiographic study in the rat

Author： Mahteme H.   Larsson B.   Sundin A.   Khamis H.   Graf W.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.40, Iss.1, 2004-01, pp. : 142-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Effect of Different Routes of Administration of 5-Fluorouracil on Thymidylate Synthase Inhibition in the Rat

By van der Wilt C.L.   Marinelli A.   Pinedo H.M.   Cloos J.   Smid K.   van de Velde C.J.H.   Peters G.J.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 754-760

Elsevier

Access to resources Recommend Favorite

5-Fluorouracil (5-FU) Continuous Intravenous Infusion Compared with Bolus Administration. Final Results of a Randomised Trial in Metastatic Colorectal Cancer

By Rougier P.   Paillot B.   LaPlanche A.   Morvan F.   Seitz J.F.   Rekacewicz C.   Laplaige P.   Jacob J.   Grandjouan S.   Tigaud J.M.   Fabri M.C.   Luboinski M.   Ducreux M.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1789-1793

Elsevier

Access to resources Recommend Favorite

Epirubicin, Cisplatin and Infusional 5-Fluorouracil (5-FU) (ECF) in Hepatobiliary Tumours

By Ellis P.A.   Norman A.   Hill A.   O'Brien M.E.R.   Nicolson M.   Hickish T.   Cunningham D.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1594-1598

Elsevier

Access to resources Recommend Favorite

Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells

By Takechi T.   Fujioka A.   Matsushima E.   Fukushima M.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1271-1277

Elsevier

Access to resources Recommend Favorite

High Dose 5-Fluorouracil (5-FU) and Folinic Acid in Advanced Colorectal Cancer Resistant to Standard Dose 5-FU Treatment: Results of a Phase II Study

By Jager E.   Klein O.   Wachter B.   Muller B.   Braun U.   Knuth A.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1717-1717

Elsevier

Access to resources Recommend Favorite